Form 4: Annexon Director William A. Jones Jr. Granted 55,000 Stock Options

Annexon, Inc. Director William A. Jones Jr. was granted 55,000 stock options with an exercise price of $2.55, aligning his interests with shareholder value.

Summary

• William A. Jones Jr., a Director of Annexon, Inc. (ANNX), acquired 55,000 derivative securities in the form of stock options.
• The transaction date for the option grant was June 5, 2025.
• The exercise price for these stock options is $2.55 per share.
• The options have an expiration date of June 5, 2035.
• The underlying shares subject to the option will vest and become exercisable as to 100% of the total number of shares on the earlier of (i) the first anniversary of June 5, 2025, or (ii) the next Annual Meeting following June 5, 2025.
• Vesting is contingent upon Mr. Jones Jr.'s continuous service as a director until the vesting date.
• Following this transaction, Mr. Jones Jr. beneficially owns 55,000 derivative securities directly.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is generally viewed positively as it aligns the director's financial interests with the company's performance and shareholder value. It's a standard compensation practice.

Positives

• The grant of stock options to a director aligns management's interests with those of shareholders, as the options gain value only if the company's stock price increases.
• This is a common form of executive and director compensation, indicating standard corporate governance practices.

Future Outlook

The stock options granted to Director William A. Jones Jr. are subject to a vesting schedule, with 100% of the shares vesting on the earlier of the first anniversary of the grant date (June 5, 2025) or the next Annual Meeting following the grant date, provided continuous service as a director.

Industry Context

The granting of stock options to directors is a standard practice across various industries, particularly in biotechnology and pharmaceutical sectors like Annexon, Inc., to incentivize long-term commitment and performance aligned with shareholder value creation.

Stakeholder Impact

• Shareholders: The option grant aims to align the director's incentives with shareholder interests, potentially leading to decisions that enhance long-term stock value.
• Employees: While not directly impacting general employees, such compensation practices for leadership can set a precedent for performance-based incentives within the company.

Next Steps

• The stock options will vest on the earlier of June 5, 2026, or the date of the next Annual Meeting following June 5, 2025, subject to the director's continuous service.

Key Dates

Keywords

Annexon Inc., ANNX, Form 4, SEC filing, insider transaction, stock options, director compensation, beneficial ownership, equity compensation, vesting schedule